PharmX names Bastas alternate director

DBG Health chief commercial officer, Alexander “Sandy” Mellis, joins PharmX board as a non-executive and independent alternate director for Dennis Bastas  PharmX Technologies has announced the appointment of Alexander Mellis as a non-executive and independent alternate director with immediate effect.  In a statement to the Australian Securities Exchange (ASX), PharmX noted that Mellis will bring